Table 3.

Cell surface expression of HLA-I and NKG2D ligands and NKG2D ligands/HLA-I ratio on medulloblastoma cell lines (HTB-185, HTB-186, HTB-187), neuroblastoma cell line (NB1691) and erythroleukaemia cell line (K562) measured by mean fluorescence intensity (MFI).

Ligands	HTB-185	HTB-186	HTB-187	NB1691	K562	Ligands	HTB-185	HTB-186	HTB-187	NB1691	K562
HLA-I	1.50	28.57	1.34	1.83	1.88	MICA/HLA-I	2.21	0.52	1.12	3.50	6.07
MICA	5.66	14.96	1.98	6.39	11.44	MICAB/HLA-I	3.78	0.50	1.48	2.50	7.29
MICAB	3.31	14.23	1.49	4.57	13.75	ULBP-1/HLA-I	3.15	0.41	1.57	4.44	7.51
ULBP-1	4.73	11.72	2.10	8.11	14.16	ULBP-2/HLA-I	1.98	1.13	1.03	4.95	8.54
ULBP-2	2.97	32.42	1.37	9.04	16.10	ULBP-3/HLA-I	2.89	0.36	1.28	2.17	2.58
ULBP-3	4.33	10.37	1.72	3.96	4.85	ULBP-4/HLA-I	1.82	0.12	1.07	2.00	2.84
ULBP-4	2.73	3.34	1.43	3.65	5.34